Nephros (NEPH) Short Interest Ratio & Short Volume $1.57 -0.03 (-1.63%) As of 03:50 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Nephros Short Interest DataNephros (NEPH) has a short interest of 4,300 shares, representing 0.05% of the float (the number of shares available for trading by the public). This marks a -12.24% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 9,913 shares to cover all short positions.Current Short Interest4,300 sharesPrevious Short Interest4,900 sharesChange Vs. Previous Month-12.24%Dollar Volume Sold Short$6,321.00Short Interest Ratio0.5 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares10,540,000 sharesFloat Size9,190,000 sharesShort Percent of Float0.05%Today's Trading Volume32,254 sharesAverage Trading Volume9,913 sharesToday's Volume Vs. Average325% Short Selling Nephros? Sign up to receive the latest short interest report for Nephros and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNEPH Short Interest Over TimeNEPH Days to Cover Over TimeNEPH Percentage of Float Shorted Over Time Nephros Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/20244,300 shares $6,321.00 -12.2%0.1%0.5 $1.47 12/15/20244,900 shares $7,595.00 -36.4%0.1%0.4 $1.55 11/30/20247,700 shares $11,935.00 No Change0.1%0.7 $1.55 11/15/20247,700 shares $12,012.00 -30.6%0.1%0.7 $1.56 10/31/202411,100 shares $16,095.00 +1,750.0%0.1%1 $1.45 10/15/2024600 shares $876.00 -76.9%0.0%0 $1.46 9/30/20242,600 shares $4,446.00 -25.7%0.0%0.2 $1.71 9/15/20243,500 shares $6,518.19 -23.9%0.0%0.3 $1.86 8/31/20244,600 shares $8,418.00 +119.1%0.1%0.4 $1.83 8/15/20242,100 shares $3,927.00 -30.0%0.0%0.2 $1.87 Get the Latest News and Ratings for NEPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nephros and its competitors with MarketBeat's FREE daily newsletter. 7/31/20243,000 shares $6,570.00 +76.5%0.0%0.2 $2.19 7/15/20241,700 shares $3,740.00 -55.3%0.0%0.1 $2.20 6/30/20243,800 shares $8,018.00 +52.0%0.0%0.3 $2.11 6/15/20242,500 shares $5,275.00 +316.7%0.0%0.2 $2.11 5/31/2024600 shares $1,308.00 -81.3%0.0%0 $2.18 5/15/20243,200 shares $6,560.00 +33.3%0.0%0.2 $2.05 4/30/20242,400 shares $5,448.00 +50.0%0.0%0.1 $2.27 4/15/20241,600 shares $3,184.00 -38.5%0.0%0.1 $1.99 3/31/20242,600 shares $5,694.00 +44.4%0.0%0.1 $2.19 3/15/20241,800 shares $3,906.00 -64.7%0.0%0.1 $2.17 2/29/20245,100 shares $16,116.00 +24.4%0.1%0.2 $3.16 2/15/20244,100 shares $14,391.00 -40.6%0.0%0.1 $3.51 1/31/20246,900 shares $24,495.00 -24.2%0.1%0.2 $3.55 1/15/20249,100 shares $31,213.00 -18.0%0.1%0.3 $3.43 12/31/202311,100 shares $38,406.00 -57.3%0.1%0.4 $3.46 12/15/202326,000 shares $74,880.00 -14.8%0.3%1.1 $2.88 11/30/202330,500 shares $69,845.00 +23.0%0.3%2.7 $2.29 11/15/202324,800 shares $51,336.00 +10.7%0.3%2.9 $2.07 10/31/202322,400 shares $36,957.76 -27.7%0.2%2.5 $1.65 10/15/202331,000 shares $50,840.00 +36.0%0.3%3.7 $1.64 9/30/202322,800 shares $33,744.00 -24.0%0.3%2.7 $1.48 9/15/202330,000 shares $42,600.00 -19.8%0.3%4.5 $1.42 8/31/202337,400 shares $61,336.00 -13.0%0.4%3.7 $1.64 8/15/202343,000 shares $64,930.00 +80.7%0.5%0.6 $1.51 7/31/202323,800 shares $32,844.00 -5.9%0.3%0.3 $1.38 7/15/202325,300 shares $35,420.00 -10.6%0.3%0.3 $1.40 6/30/202328,300 shares $43,865.00 -6.0%0.3%0.4 $1.55 6/15/202330,100 shares $44,849.00 +51.3%0.3%0.4 $1.49 5/31/202319,900 shares $31,840.00 +9.9%0.2%0.2 $1.60 5/15/202318,100 shares $22,697.40 -13.8%0.2%1.1 $1.25Bill Gates’ is about to mint millionaires (again) with Stargate. (Ad)This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.Click here and I’ll tell you everything you need to know. 4/30/202321,000 shares $29,820.00 -7.9%0.2%1.3 $1.42 4/15/202322,800 shares $32,376.00 -4.6%0.3%1.3 $1.42 3/31/202323,900 shares $25,570.61 +17.7%0.3%1.3 $1.07 3/15/202320,300 shares $20,503.00 -18.8%0.2%1 $1.01 2/28/202325,000 shares $27,250.00 +12.6%0.3%1.1 $1.09 2/15/202322,200 shares $29,304.00 +30.6%N/A0.8 $1.32 1/31/202317,000 shares $22,948.30 -32.5%N/A0.6 $1.35 1/15/202325,200 shares $29,736.00 +50.9%N/A0.9 $1.18 12/30/202216,700 shares $19,325.24 -51.2%N/A0.6 $1.16 12/15/202234,200 shares $37,339.56 +12.1%N/A1.2 $1.09 11/30/202230,500 shares $31,720.00 +64.0%N/A1.1 $1.04 11/15/202218,600 shares $19,768.08 -14.3%N/A0.3 $1.06 10/31/202221,700 shares $22,785.00 -35.6%N/A0.4 $1.05 10/15/202233,700 shares $38,418.00 +15.4%N/A0.6 $1.14 9/30/202229,200 shares $26,572.00 +15.0%0.3%0.5 $0.91 9/15/202225,400 shares $30,734.00 -52.3%0.3%0.4 $1.21 8/31/202253,200 shares $75,012.00 +51.1%0.6%1 $1.41 8/15/202235,200 shares $60,192.00 +2.3%0.4%1.5 $1.71 7/31/202234,400 shares $51,256.00 +5.2%0.4%0.7 $1.49 7/15/202232,700 shares $50,031.00 -22.5%N/A0.6 $1.53 6/30/202242,200 shares $64,566.00 +32.7%N/A0.9 $1.53 6/15/202231,800 shares $51,834.00 -37.7%N/A0.7 $1.63 5/31/202251,000 shares $94,350.00 +82.1%0.6%0.8 $1.85 5/15/202228,000 shares $57,400.00 No Change0.3%0.4 $2.05 4/30/202228,000 shares $111,440.00 +7.7%0.3%0.7 $3.98 4/15/202226,000 shares $117,520.00 -3.0%0.3%0.8 $4.52 3/31/202226,800 shares $117,920.00 -15.2%0.3%0.8 $4.40 3/15/202231,600 shares $122,924.00 +26.4%0.4%0.9 $3.89 2/28/202225,000 shares $113,250.00 -13.2%0.3%1 $4.53 2/15/202228,800 shares $139,680.00 +20.0%0.3%1.5 $4.85 1/31/202224,000 shares $110,880.00 +3.9%0.3%1.5 $4.62 1/15/202223,100 shares $121,275.00 +9.0%0.3%1.7 $5.25 12/31/202121,200 shares $125,080.00 +12.8%0.2%1.8 $5.90 12/15/202118,800 shares $132,916.00 +5.0%0.2%2.3 $7.07 11/30/202117,900 shares $124,405.00 +16.2%0.2%2.5 $6.95 11/15/202115,400 shares $115,500.00 -3.8%0.2%2.3 $7.50 10/29/202116,000 shares $125,440.00 +8.8%0.2%2.3 $7.84 10/15/202114,700 shares $114,072.00 -9.8%0.2%2 $7.76 9/30/202116,300 shares $142,951.00 -10.9%0.2%2.4 $8.77 9/15/202118,300 shares $163,785.00 +24.5%0.2%2 $8.95 8/31/202114,700 shares $120,687.00 +17.6%0.2%1.7 $8.21 8/13/202112,500 shares $99,000.00 -28.2%0.1%1.4 $7.92 7/30/202117,400 shares $145,464.00 +0.6%0.2%1.9 $8.36 7/15/202117,300 shares $156,046.00 -44.7%0.2%1.7 $9.02 6/30/202131,300 shares $317,657.44 +82.0%0.4%3 $10.15 6/15/202117,200 shares $154,800.00 +22.9%0.2%1.5 $9.00 5/28/202114,000 shares $122,500.00 +15.7%0.2%1.1 $8.75 5/14/202112,100 shares $97,042.00 No ChangeN/A0.9 $8.02 4/30/202112,100 shares $95,469.00 +3.4%N/A0.8 $7.89 4/15/202111,700 shares $90,090.00 +9.4%N/A0.7 $7.70Bill Gates’ is about to mint millionaires (again) with Stargate. (Ad)This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.Click here and I’ll tell you everything you need to know. 3/31/202110,700 shares $73,509.00 +18.9%N/A0.6 $6.87 3/15/20219,000 shares $67,590.00 -9.1%N/A0.5 $7.51 2/26/20219,900 shares $75,933.00 -20.8%N/A0.6 $7.67 2/12/202112,500 shares $106,875.00 +54.3%N/A0.6 $8.55 1/29/20218,100 shares $68,283.00 -8.0%N/A0.4 $8.43 1/15/20218,800 shares $70,400.00 -3.3%N/A0.6 $8.00 12/31/20209,100 shares $75,803.00 -18.0%N/A0.6 $8.33 12/15/202011,100 shares $82,029.00 +26.1%N/A0.7 $7.39 11/30/20208,800 shares $53,328.00 +23.9%N/A0.6 $6.06 11/15/20207,100 shares $44,446.00 -65.5%N/A0.5 $6.26 10/30/202020,600 shares $131,840.00 -7.6%N/A1.8 $6.40 10/15/202022,300 shares $148,072.00 +75.6%N/A1.9 $6.64 9/30/202012,700 shares $91,821.00 -26.2%N/A1 $7.23 9/15/202017,200 shares $121,260.00 +4.9%N/A1.4 $7.05 NEPH Short Interest - Frequently Asked Questions What is Nephros' current short interest? Short interest is the volume of Nephros shares that have been sold short but have not yet been covered or closed out. As of December 31st, traders have sold 4,300 shares of NEPH short. 0.05% of Nephros' shares are currently sold short. Learn More on Nephros' current short interest. What is a good short interest percentage for Nephros? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.05% of Nephros' floating shares are currently sold short. Is Nephros' short interest increasing or decreasing? Nephros saw a drop in short interest during the month of December. As of December 31st, there was short interest totaling 4,300 shares, a drop of 12.2% from the previous total of 4,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Nephros' float size? Nephros currently has issued a total of 10,540,000 shares. Some of Nephros' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Nephros currently has a public float of 9,190,000 shares. How does Nephros' short interest compare to its competitors? 0.05% of Nephros' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Nephros: Cytosorbents Co. (2.65%), Apyx Medical Co. (0.39%), DIH Holding US, Inc. (0.62%), iCAD, Inc. (0.86%), Inovio Pharmaceuticals, Inc. (12.16%), Lucid Diagnostics Inc. (1.78%), Nutriband Inc. (1.60%), CollPlant Biotechnologies Ltd. (0.08%), Modular Medical, Inc. (1.01%), Outset Medical, Inc. (4.68%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short Nephros stock? Short selling NEPH is an investing strategy that aims to generate trading profit from Nephros as its price is falling. NEPH shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Nephros? A short squeeze for Nephros occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NEPH, which in turn drives the price of the stock up even further. How often is Nephros' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NEPH, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies Cytosorbents Short Squeeze Apyx Medical Short Squeeze DIH Holding US Short Squeeze iCAD Short Squeeze Inovio Pharmaceuticals Short Squeeze Lucid Diagnostics Short Squeeze Nutriband Short Squeeze CollPlant Biotechnologies Short Squeeze Modular Medical Short Squeeze Outset Medical Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NEPH) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nephros, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nephros With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NEPH Stock Alerts